Biotech Values

[DewDiligence]

In practice, legitimate companies and legitimate investment banks do not execute public offerings that are close in time to major open-market sales by the company’s executive officers.

Moreover, your argument that DNDN did not get off a public offering because they were “not prepared” does not hold water. DNDN had an active SEC shelf registration (and still does); the whole point of having an active shelf registration is that a company can execute a public offering immediately with no SEC scrutiny.